ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 52 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,000 | -21.6% | 34,400 | 0.0% | 0.00% | – |
Q2 2022 | $37,000 | -33.9% | 34,400 | -22.9% | 0.00% | – |
Q1 2022 | $56,000 | +40.0% | 44,644 | +79.7% | 0.00% | – |
Q4 2021 | $40,000 | -55.6% | 24,844 | -9.8% | 0.00% | – |
Q3 2021 | $90,000 | -42.7% | 27,544 | +10.9% | 0.00% | – |
Q2 2021 | $157,000 | – | 24,844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 242,237 | $511,000 | 0.10% |
CVI Holdings, LLC | 432,305 | $912,000 | 0.06% |
Virtu Financial LLC | 271,937 | $574,000 | 0.04% |
XTX Topco Ltd | 20,392 | $43,000 | 0.02% |
Newbridge Financial Services Group, Inc. | 7,000 | $15,000 | 0.01% |
Renaissance Technologies | 3,304,140 | $6,972,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 22,925 | $48,000 | 0.01% |
Bienville Capital Management, LLC | 28,379 | $60,000 | 0.01% |
Cutler Group LLC / CA | 223,100 | $116,000 | 0.01% |
Royal Fund Management, LLC | 15,000 | $31,000 | 0.01% |